Strs Ohio Rocket Pharmaceuticals, Inc. Transaction History

Strs Ohio

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$20.66 - $26.72 $18,594 - $24,048	900 Added 52.94%	2,600 $55,000
Q1 2024 May 13, 2024	BUY	$26.16 - $30.74 $44,472 - $52,258	1,700 New	1,700 $45,000
Q1 2023 Aug 02, 2023	BUY	$15.79 - $22.6 $9,474 - $13,560	600 New	600 $10,000
Q4 2022 Jan 26, 2023	BUY	$15.5 - $22.76 $9,300 - $13,656	600 New	600 $11,000
Q3 2019 Oct 21, 2019	SELL	$10.85 - $14.78 $0 - $0	0 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$15.0 - $19.81 $94,500 - $124,802	-6,300 Closed	0 $0
Q1 2019 Apr 19, 2019	BUY	$13.45 - $19.01 $9,415 - $13,307	700 Added 12.5%	6,300 $110,000
Q3 2018 Oct 19, 2018	SELL	$18.5 - $25.49 $9,250 - $12,745	-500 Reduced 8.2%	5,600 $137,000
Q2 2018 Aug 06, 2018	BUY	$14.58 - $23.0 $88,938 - $140,300	6,100 New	6,100 $119,000

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $890M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.